Published in Eur J Clin Pharmacol on November 12, 2015
Adherence to medication. N Engl J Med (2005) 39.77
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol (1997) 8.88
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet (2008) 8.53
Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19
Medication adherence: its importance in cardiovascular outcomes. Circulation (2009) 5.30
Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82
Thinking outside the pillbox--medication adherence as a priority for health care reform. N Engl J Med (2010) 3.54
Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J (2008) 3.40
The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27
Policy: Twenty tips for interpreting scientific claims. Nature (2013) 2.56
Knowing but not doing: selecting priority conservation areas and the research-implementation gap. Conserv Biol (2008) 2.30
How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials. Fam Pract (2007) 1.51
Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother (2009) 1.46
Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev (2010) 1.43
The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review. Am J Med (2013) 1.36
Primary medication adherence in a rural population: the role of the patient-physician relationship and satisfaction with care. J Am Board Fam Med (2006) 1.34
Benchmarking: a method for continuous quality improvement in health. Healthc Policy (2012) 1.30
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol (2005) 1.29
Medication adherence trends with statins. Adv Ther (2005) 1.29
Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. Am J Manag Care (2005) 1.22
Statin discontinuation in high-risk patients: a systematic review of the evidence. Curr Pharm Des (2011) 1.20
Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy (2005) 1.19
Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiol Drug Saf (2006) 1.14
Long-term adherence to statin treatment in diabetes. Diabet Med (2008) 1.12
Patients' perspectives on nonadherence to statin therapy: a focus-group study. Perm J (2010) 1.12
How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag (2007) 1.12
Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease. Br J Clin Pharmacol (2004) 1.10
Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc (2003) (2012) 1.10
Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. Am J Med (2013) 1.06
Statin cost effectiveness in primary prevention: a systematic review of the recent cost-effectiveness literature in the United States. BMC Res Notes (2012) 1.02
Recognizing and improving patient nonadherence to statin therapy. Curr Atheroscler Rep (2008) 1.01
Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims. Curr Med Res Opin (2010) 1.01
The clinical and economic burden of nonadherence with antihypertensive and lipid-lowering therapy in hypertensive patients. Value Health (2008) 0.98
Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. Pharmacoeconomics (2004) 0.96
Patient and physician factors associated with adherence to diabetes medications. Diabetes Educ (2012) 0.95
Improving the physician-patient cardiovascular risk dialogue to improve statin adherence. BMC Fam Pract (2009) 0.93
Interventions promoting adherence to cardiovascular medicines. Int J Clin Pharm (2012) 0.90
Adherence to lipid-lowering treatment: the patient perspective. Patient Prefer Adherence (2012) 0.89
Adherence with statins over 8 years in a usual care setting. Am J Manag Care (2008) 0.86
Patterns of medication adherence and health care utilization among patients with chronic disease who were enrolled in a pharmacy assistance program. N C Med J (2014) 0.83
The impact on patient health outcomes of interventions targeting the patient-physician relationship. Patient (2009) 0.81
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases. Atherosclerosis (2011) 0.78
Improving adherence to hormone replacement therapy with effective patient-physician communication. Am J Obstet Gynecol (1999) 0.77
Statin treatment and the natural history of atherosclerotic-related diseases: pathogenic mechanisms and the risk-benefit profile. Curr Pharm Des (2004) 0.77
Improving the quality of preventive cardiovascular care provided by primary care physicians: insights from a US Quality Improvement Organization. Int J Qual Health Care (2006) 0.77
Cost effectiveness of statin therapy for the primary prevention of coronary heart disease. Ir Med J (2006) 0.76
Cost-effectiveness of statin medications. Am Psychol (2001) 0.76
Data used to improve quality of health care. Tex Med (2000) 0.76
Reply to: "Statins probably do not cause cataracts". Atherosclerosis (2016) 0.75
Statin use and risk of cataract: A nested case-control study within a healthcare database. Atherosclerosis (2016) 0.75